Search results
NLS Pharmaceutics Announces Publication of New Patent Application for Next-Gen Dual Non-Sulfonamide...
Digital Journal· 3 days agoThe patent will be used by NLS pursuant to its existing and previously announced license agreement with Aexon Labs. "This new patent application covers groundbreaking advancements in a novel ...
ADHD and sleep problems: the complete guide
The Telegraph via Yahoo News· 6 days agoWith minds that whir away at night as soon as their heads hit the pillow, people with ADHD often struggle to get to sleep, and when they do their sleep...
A strange and occasionally antagonistic interview with Mötley Crüe
Louder Sound via Yahoo News· 3 days agoThe mood is so arid and bloodless it’s a wonder that mass narcolepsy hasn’t set in. As F. Scott...
I now have a personal sleep coach, and you can have one too
TechRadar· 5 days agoSleep is one of those things where everyone seems to have an opinion. Recent years have seen a new...
Citi maintains buy on Axsome, price target steady at $125 By Investing.com
Investing.com· 2 days agoOn Wednesday, Citi reaffirmed its Buy rating on Axsome Therapeutics (NASDAQ:AXSM) with a consistent...
‘Wedding Day at the Cro-Magnons’’ Review: A Bittersweet Premiere
New York Times· 4 days agoAn Arabic production of Wajdi Mouawad’s 1991 work, planned to open in Lebanon, was canceled because...
Axsome maintains Buy stock rating amid short report claims By Investing.com
Investing.com· 3 days agoOn Tuesday, Guggenheim reaffirmed its Buy rating on Axsome Therapeutics (NASDAQ:AXSM), despite a...
Dogged by Bad Health and Bad Reviews, Darwin Needed Friends Like These
New York Times· 5 days agoIn a new book, the medical historian Howard Markel homes in on Darwin’s physical and emotional...
Ben Folds caps off Three Rivers Arts Festival on a high note
Pittsburgh Tribune-Review· 4 days agoOn Sunday night, the final evening of the 2024 Three Rivers Arts Festival, Pittsburghers streamed...
Avadel Pharmaceuticals (NASDAQ:AVDL) Receives New Coverage from Analysts at Rodman & Renshaw
ETF DAILY NEWS· 1 day agoRodman & Renshaw assumed coverage on shares of Avadel Pharmaceuticals (NASDAQ:AVDL – Free Report) in a research note issued to investors on Wednesday morning, Marketbeat reports. The brokerage ...